Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ: BOLT · IEX Real-Time Price · USD
0.930
+0.030 (3.32%)
At close: Nov 27, 2023, 4:00 PM
0.910
-0.020 (-2.14%)
After-hours: Nov 27, 2023, 5:49 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018
Revenue
5.731.260.230.220
Revenue Growth (YoY)
354.68%445.45%7.44%--
Gross Profit
5.731.260.230.220
Selling, General & Admin
22.9318.399.065.182.21
Research & Development
73.1275.6640.36269.42
Operating Expenses
96.0594.0549.4131.1811.63
Operating Income
-90.32-92.79-49.18-30.97-11.63
Other Expense / Income
-2.225.811.55-0.48-0.04
Pretax Income
-88.1-98.59-60.73-30.49-11.59
Net Income
-88.1-98.59-60.73-30.49-11.59
Shares Outstanding (Basic)
3733222
Shares Outstanding (Diluted)
3733222
Shares Change
12.54%1479.05%5.46%20.76%-
EPS (Basic)
-2.36-2.97-28.89-15.29-7.02
EPS (Diluted)
-2.36-2.97-28.89-15.29-7.02
Free Cash Flow
-78.46-59.4-50.57-26.85-10.16
Free Cash Flow Per Share
-2.10-1.79-24.05-13.47-6.16
Gross Margin
100.00%100.00%100.00%100.00%-
Operating Margin
-1576.56%-7364.13%-21290.91%-14404.19%-
Profit Margin
-1537.76%-7824.68%-26289.18%-14180.00%-
Free Cash Flow Margin
-1369.47%-4714.60%-21891.77%-12488.84%-
EBITDA
-83.21-94.92-58.22-29.16-11.29
EBITDA Margin
-1452.38%-7533.25%-25205.19%-13561.86%-
Depreciation & Amortization
4.893.672.51.330.3
EBIT
-88.1-98.59-60.73-30.49-11.59
EBIT Margin
-1537.76%-7824.68%-26289.18%-14180.00%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).